Acino Holding AG (LTS:0QM8) Change In Receivables: CHF5.20 Mil (TTM As of Dec. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Acino Holding AG Change In Receivables?

Acino Holding AG LTS:0QM8 Change In Receivables is CHF5.20 Mil as of Dec. 2013.

Acino Holding AG's change in receivables for the quarter that ended in Dec. 2013 was CHF5.20 Mil. It means Acino Holding AG's Accounts Receivable declined by CHF5.20 Mil from Dec. 2012 to Dec. 2013 .

Acino Holding AG's change in receivables for the fiscal year that ended in Dec. 2013 was CHF5.20 Mil. It means Acino Holding AG's Accounts Receivable declined by CHF5.20 Mil from Dec. 2012 to Dec. 2013 .

Acino Holding AG's Accounts Receivable for the quarter that ended in Dec. 2013 was CHF65.70 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Acino Holding AG's Days Sales Outstanding for the six months ended in Dec. 2013 was 37.33.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Acino Holding AG's liquidation value for the six months ended in Dec. 2013 was CHF-130.30 Mil.

Acino Holding AG  (LTS:0QM8) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Acino Holding AG's Days Sales Outstanding for the quarter that ended in Dec. 2013 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=65.699/321.15*91
=37.33

2. In Ben Graham's calculation of liquidation value, Acino Holding AG's accounts receivable are only considered to be worth 75% of book value:

Acino Holding AG's liquidation value for the quarter that ended in Dec. 2013 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=12.269-226.359+0.75 * 65.699+0.5 * 69.035
=-130.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acino Holding AG Change In Receivables Related Terms

Acino Holding AG Change In Receivables Historical Data

* Premium members only.

The historical data trend for Acino Holding AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acino Holding AG Change In Receivables Chart

Acino Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.39 -26.03 24.08 -4.27 5.20

Acino Holding AG Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -6.39 -26.03 24.08 -4.27 5.20

Acino Holding AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2013 was CHF5.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of CHF5.20 Mil mean?
Acino Holding AG (LTS:0QM8) has a Change In Receivables of CHF5.20 Mil as of Dec. 2013. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Acino Holding AG and its competitors.
Is Acino Holding AG's Change In Receivables too high?
Acino Holding AG's current Change In Receivables is CHF5.20 Mil.
How does Acino Holding AG's Change In Receivables compare to competitors?
Acino Holding AG's Change In Receivables of CHF5.20 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Acino Holding AG and its competitors. Acino Holding AG's current Change In Receivables is CHF5.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acino Holding AG stock overvalued right now?
Acino Holding AG (LTS:0QM8) has a current Change In Receivables of CHF5.20 Mil. The current Change In Receivables is CHF5.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Acino Holding AG (LTS:0QM8), the current Change In Receivables is CHF5.20 Mil as of Dec. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acino Holding AG Business Description

Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.